GlassScriptPhysician profile
Meaghan M Reynolds
NPI 1477782324
$23,756.88
in general payments reported to CMS, 2019-2025
60 companies · $6,005 in 2025
The $6,005 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,644 · 2022: $3,758 · 2023: $4,927 · 2024: $6,424 · 2025: $6,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,187.95 |
| Education | $167.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,016.39 | 2021-2025 | |
| Lundbeck LLC | $1,780.93 | 2021-2025 | Vyepti, Rexulti |
| Novartis Pharmaceuticals Corporation | $1,689.76 | 2021-2025 | |
| Biogen, INC. | $1,233.91 | 2021-2025 | Tysabri, Vumerity, Leqembi |
| Sk Life Science, INC. | $1,147.56 | 2021-2025 | Xcopri |
| Mdd US Operations, LLC | $947.94 | 2021-2025 | Apokyn, Gocovri, Gocovri |
| Teva Pharmaceuticals USA, INC. | $885.51 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Csl Behring | $842.94 | 2021-2025 | Hizentra |
| Pfizer INC. | $736.62 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $726.20 | 2023-2025 | Purified Cortrophin Gel |
| Eisai INC. | $717.39 | 2022-2025 | |
| Ucb, INC. | $679.52 | 2022-2025 | Zilbrysq, Briviact, Nayzilam |
| Amneal Pharmaceuticals LLC | $676.06 | 2021-2025 | Ongentys, Crexont, Rytary |
| Lilly USA, LLC | $671.91 | 2021-2025 | Kisunla, Reyvow, Emgality |
| Emd Serono, INC. | $664.10 | 2022-2025 | Mavenclad |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $658.55 | 2021-2025 | Acthar |
| Merz Pharmaceuticals, LLC | $656.89 | 2023-2025 | Xeomin |
| Alexion Pharmaceuticals, INC. | $613.47 | 2022-2025 | Ultomiris, Soliris |
| Celgene Corporation | $459.14 | 2021-2025 | Zeposia |
| Genzyme Corporation | $426.55 | 2021-2025 | |
| Amgen INC. | $329.95 | 2021-2025 | Aimovig, Uplizna |
| Janssen Pharmaceuticals, INC | $292.02 | 2021-2023 | Ponvory |
| Genentech USA, INC. | $291.30 | 2021-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Alnylam Pharmaceuticals INC. | $272.61 | 2023 | Onpattro, Amvuttra |
| Sunovion Pharmaceuticals INC. | $262.77 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $261.53 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $260.58 | 2022 | |
| Neurocrine Biosciences, INC. | $229.55 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $228.55 | 2023-2025 | Rexulti, Nuedexta |
| Axsome Therapeutics, INC. | $204.42 | 2023-2025 | Sunosi |
| Neurelis, INC. | $192.30 | 2021-2025 | Valtoco |
| Tg Therapeutics, INC. | $151.26 | 2023-2024 | |
| Grifols USA, LLC | $141.38 | 2022-2024 | Gamunex-C |
| Tanabe Pharma America, INC. | $135.23 | 2023-2025 | Radicava |
| Acadia Pharmaceuticals INC | $129.83 | 2022-2024 | Nuplazid |
| Impel Pharmaceuticals INC. | $112.22 | 2023 | Trudhesa |
| Supernus Pharmaceuticals, INC. | $100.55 | 2025 | Qelbree |
| Argenx US, INC. | $99.77 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Takeda Pharmaceuticals U.S.A., INC. | $92.54 | 2021-2025 | Hyqvia |
| Kyowa Kirin, INC. | $79.19 | 2022-2024 | Nourianz |
| Idorsia Pharmaceuticals US INC | $77.00 | 2022-2023 | Quviviq |
| Harmony Biosciences LLC | $72.52 | 2025 | |
| Acorda Therapeutics, INC | $64.77 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $56.43 | 2023-2025 | Wainua |
| Allergan, INC. | $55.24 | 2021 | |
| Ge Healthcare | $42.83 | 2023-2024 | |
| Life Molecular Imaging LTD | $34.27 | 2025 | Neuraceq |
| Scilex Pharmaceuticals INC. | $24.88 | 2024 | |
| Vanda Pharmaceuticals INC. | $24.66 | 2025 | Fanapt |
| Amylyx Pharmaceuticals, INC. | $24.45 | 2023 | Relyvrio |
| Insightec,INC | $23.41 | 2024 | Exablate |
| Corium, LLC | $21.72 | 2024 | Azstarys |
| Kedrion Biopharma, INC. | $21.13 | 2024 | Rhogam Ultra-Filtered Plus, Albuked, Koate |
| Jazz Pharmaceuticals INC. | $20.46 | 2021 | |
| Cycle Pharmaceuticals INC | $19.75 | 2025 | Bafiertam, Tascenso Odt |
| Catalyst Pharmaceuticals, INC. | $19.24 | 2023 | Fycompa |
| Vertex Pharmaceuticals Incorporated | $15.19 | 2025 | |
| Xeris Pharmaceuticals, INC. | $14.01 | 2025 | Keveyis |
| Avion Pharmaceuticals | $13.87 | 2022 | |
| Upsher-Smith Laboratories LLC | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meaghan Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.